- Abzena History
We are proud of our 20+ years
of history moving medicine forward.
- About Abzena
We are a leading complex biologics
and bioconjugates CDMO + CRO.
- Abzena Locations
We operate from state-of-the-art
facilities in the US and the UK.
- Moving Medicine Forward
It's what we do. We take on complex
biologic & bioconjugate programs.
- Abzena History
Search results
In new criteria for Alzheimer’s, some see much-needed progress while others fear profit may be...
CNN.com· 5 days agoWith another pricey Alzheimer’s disease treatment expected to receive an approval decision soon, the...
Vestibular hair cells are more prone to damage by excessive acceleration insult in the mouse with...
Nature· 4 days agoAll of the animal experimental procedures and a study enrolling humans were approved by the Yonsei University Health System Institutional Animal Care and Use Committee (approval No. 2016-0254 ...
FDA approves Eli Lilly's treatment which slows symptoms down
Daily Mail· 4 days agoMade by Indianapolis-based Eli Lilly, donanemab is a monoclonal antibody treatment designed to slow...
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Zacks via Yahoo Finance UK· 6 days agoAbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult...
Kourtney Kardashian And Sofia Richie Are Sipping Colostrum—Should You?
Forbes· 6 days agoThe year 2024 has predominantly been defined by cowboy core. The rise of bovine colostrum has also...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance UK· 4 days agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
FDA approves second Alzheimer’s drug that can modestly slow disease
Irish Examiner· 4 days agoRolling coverage of the international stories of interest to our readers
Cambridge street that was once home to the University's famous alumni
Cambridge Evening News· 7 days agoCambridge has a rich academic history, dating all the way back to 1209. The university also has a...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo News UK· 4 days agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
Kinetic features dictate sensorimotor alignment in the superior colliculus - Nature
Nature· 4 days agoMotor units in the superior colliculus of mice exhibit poorly defined representation of static visual fields and instead rely largely on kinetic visual features to link visual inputs to behavioural outcomes.